Publications and communications of Erik Maquoi

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (10 February 2023). Effect of PEG Anchor and Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking Method. Pharmaceutics, 15 (2). doi:10.3390/pharmaceutics15020597

Ledoux, A., Hamann, C., Bonnet, O., Jullien, K., Quetin-Leclercq, J., Tchinda, A., Smadja, J., Gauvin-Bialecki, A., Maquoi, E., & Frederich, M. (25 January 2023). Bioactive Clerodane Diterpenoids from the Leaves of Casearia coriacea Vent. Molecules, 28 (3), 1197. doi:10.3390/molecules28031197

Gommes, C., Louis, T., Bourgot, I., Blacher, S., Noël, A., & Maquoi, E. (2023). Remodelling of the fibre-aggregate structure of collagen gels by cancer-associated fibroblasts: a time-resolved grey-tone image analysis based on stochastic modelling. Frontiers in Immunology, 13. doi:10.3389/fimmu.2022.988502

PAYE, A., Truong, A., Yip, C., Cimino, J., Blacher, S., Munaut, C., Cataldo, D., Foidart, J. M., Maquoi, E., Collignon, J., Delvenne, P., Jerusalem, G., Noël, A., & Sounni, N. E. (15 February 2022). Editor's Note: EGFR Activation and Signaling in Cancer Cells Are Enhanced by the Membrane-Bound Metalloprotease MT4-MMP. Cancer Research, 82 (4), 734. doi:10.1158/0008-5472.CAN-21-4292

Saby, C., Maquoi, E., Saltel, F., & Morjani, H. (22 December 2021). Collagen and Discoidin Domain Receptor 1 Partnership: A Multifaceted Role in the Regulation of Breast Carcinoma Cell Phenotype. Frontiers in Cell and Developmental Biology, 9. doi:10.3389/fcell.2021.808625

Gallez, A., Blacher, S., Maquoi, E., Konradowski, E., Joiret, M., Primac, I., Gérard, C., Taziaux, M., Houtman, R., Geris, L., Lenfant, F., Marangoni, E., Sounni, N. E., Foidart, J.-M., Noël, A., & Pequeux, C. (2021). Estetrol combined to progestogen for menopause or contraception indication is neutral on breast cancer. Cancers. doi:10.3390/cancers13102486

Luis, G.* , Godfroid, A.* , Nishiumi, S., Cimino, J., Blacher, S., Maquoi, E., Wery, C., Collignon, A., Longuespée, R., MONTERORUIZ, L., Dassoul, I., Maloujahmoum, N., Pottier, C., Mazzucchelli, G., De Pauw, E., Bellahcene, A., Yoshida, M., Noël, A., & Sounni, N. E. (2021). Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. Redox Biology, 43, 102006. doi:10.1016/j.redox.2021.102006

Bourgot, I.* , Primac, I.* , Louis, T., Noël, A., & Maquoi, E. (18 August 2020). Reciprocal Interplay Between Fibrillar Collagens and Collagen-Binding Integrins: Implications in Cancer Progression and Metastasis. Frontiers in Oncology, 10 (1488). doi:10.3389/fonc.2020.01488

Saby, C., Collin, G., Sinane, M., Buache, E., VAN GULICK, L., Saltel, F., Maquoi, E., & Morjani, H. (June 2020). DDR1 and MT1-MMP expression are determinant for triggering BIK-mediated apoptosis by 3D type I collagen matrix in invasive basal-like breast carcinoma cells [Poster presentation]. AACR Meeting, United States.

Primac, I., Maquoi, E., Blacher, S., Heljasvaara, R., Van Deun, J., Smeland, H. Y. H., Canale, A., Louis, T., Stuhr, L., Sounni, N. E., Cataldo, D., Pihlajaniemi, T., Pequeux, C., De Wever, O., Gullberg, D., & Noël, A. (09 July 2019). Stromal integrin alpha11 regulates PDGFR-beta signaling and promotes breast cancer progression. Journal of Clinical Investigation, 130. doi:10.1172/JCI125890

Saby, C., Collin, G., Sinane, M., Buache, E., Van Gulick, L., Saltel, F., Maquoi, E.* , & Morjani, H.*. (2019). DDR1 and MT1-MMP Expression Levels Are Determinant for Triggering BIK-Mediated Apoptosis by 3D Type I Collagen Matrix in Invasive Basal-Like Breast Carcinoma Cells. Frontiers in Pharmacology, 10, 462. doi:10.3389/fphar.2019.00462

Assent, D., Bourgot, I., Hennuy, B., Geurts, P., Noël, A., Foidart, J.-M., & Maquoi, E. (2015). A Membrane-Type-1 Matrix Metalloproteinase (MT1-MMP) - Discoidin Domain Receptor 1 Axis Regulates Collagen-Induced Apoptosis in Breast Cancer Cells. PLoS ONE, 10 (3), 0116006. doi:10.1371/journal.pone.0116006

Paye, A., Truong, A., Yip, C., Cimino, J., Blacher, S., Munaut, C., Cataldo, D., Foidart, J.-M., Maquoi, E., COLLIGNON, J., Delvenne, P., Jerusalem, G., Noël, A.* , & Sounni, N. E.*. (October 2014). EGFR activation and signaling in cancer cells are enhanced by the membrane-bound metalloprotease MT4-MMP. Cancer Research, 74 (23), 6758-70. doi:10.1158/0008-5472.CAN-13-2994

Noël, A., Gutierrez-Fernandez, A., Sounni, N. E., Behrendt, N., Maquoi, E., Lund, I., Cal, S., Hoyer-Hansen, G., & Lopez-Otin, C. (2012). New and Paradoxical Roles of Matrix Metalloproteinases in the Tumor Microenvironment. Frontiers in Pharmacology, 3 (140), 1. doi:10.3389/fphar.2012.00140

LORQUET, S., Berndt, S., Blacher, S., Gengoux, E., Peulen, O., Maquoi, E., Noël, A., Foidart, J.-M., Munaut, C., & Pequeux, C. (2010). Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment. FASEB Journal, 24 (10), 3782-95. doi:10.1096/fj.09-149070

Van Steenkiste, M., Oltenfreiter, R., Frankenne, F., Vervoort, L., Maquoi, E., Noël, A., Foidart, J.-M., Van De Wiele, C., & De Vos, F. (2010). Membrane type 1 matrix metalloproteinase detection in tumors, using the iodinated endogenous [123I]-tissue inhibitor 2 of metalloproteinases as imaging agent. Cancer Biotherapy and Radiopharmaceuticals, 25 (5), 511-20. doi:10.1089/cbr.2010.0789

Noël, A., Jost, M., & Maquoi, E. (2008). Matrix metalloproteinases at cancer tumor-host interface. Seminars in Cell and Developmental Biology, 19, 52-60. doi:10.1016/j.semcdb.2007.05.011

Chabottaux, V., Sounni, N. E., Pennington, C. J., English, W. R., van den Brule, F., Blacher, S., Gilles, C., Munaut, C., Maquoi, E., Lopez-Otin, C., Murphy, G., Edwards, D. R., Foidart, J.-M., & Noël, A. (15 May 2006). Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases. Cancer Research, 66 (10), 5165-5172. doi:10.1158/0008-5472.CAN-05-3012

Vörös, G., Maquoi, E., Demeulemeester, D., Clerx, N., Collen, D., & Lijnen, R. (October 2005). Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology, 146 (10), 4545-4554. doi:10.1210/en.2005-0532

Maquoi, E., Sounni, N. E., Devy, L., Olivier, F., Frankenne, F., Krell, H. W., Grams, F., Foidart, J.-M., & Noël, A. (15 June 2004). Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor. Clinical Cancer Research, 10 (12, Pt 1), 4038-4047. doi:10.1158/1078-0432.CCR-04-0125

Noël, A., Maillard, C., Rocks, N., Jost, M., Chabottaux, V., Sounni, N. E., Maquoi, E., Cataldo, D., & Foidart, J.-M. (June 2004). Membrane associated proteases and their inhibitors in tumour angiogenesis. Journal of Clinical Pathology, 57 (6), 577-584. doi:10.1136/jcp.2003.014472

Sounni, N. E., Roghi, C., Chabottaux, V., Janssen, M., Munaut, C., Maquoi, E., Galvez, B. G., Gilles, C., Frankenne, F., Murphy, G., Foidart, J.-M., & Noël, A. (02 April 2004). Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases. Journal of Biological Chemistry, 279 (14), 13564-13574. doi:10.1074/jbc.M307688200

Maquoi, E., Peyrollier, K., Noël, A., Foidart, J.-M., & Frankenne, F. (01 July 2003). Regulation of membrane-type 1 matrix metalloproteinase activity by vacuolar H+-ATPases. Biochemical Journal, 373 (Pt 1), 19-24. doi:10.1042/BJ20030170

Maquoi, E., Demeulemeester, D., Vörös, G., Collen, D., & Lijnen, R. (April 2003). Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation. Thrombosis and Haemostasis, 89 (4), 696-704. doi:10.1055/s-0037-1613586

Lijnen, R., Demeulemeester, D., Van Hoef, B., Collen, D., & Maquoi, E. (February 2003). Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice. Thrombosis and Haemostasis, 89 (2), 249-255. doi:10.1055/s-0037-1613439

Vörös, G., Maquoi, E., Collen, D., & Lijnen. (03 January 2003). Differential expression of plasminogen activator inhibitor-1, tumor necrosis factor-alpha, TNF-alpha converting enzyme and ADAMTS family members in murine fat territories. Biochimica et Biophysica Acta-Gene Structure and Expression, 1625 (1), 36-42. doi:10.1016/S0167-4781(02)00589-4

Lijnen, R., Maquoi, E., Demeulemeester, D., Van Hoef, B., & Collen, D. (August 2002). Modulation of fibrinolytic and gelatinolytic activity during adipose tissue development in a mouse model of nutritionally induced obesity. Thrombosis and Haemostasis, 88 (2), 345-353. doi:10.1055/s-0037-1613208

Maquoi, E., Munaut, C., Colige, A., Collen, D., & Lijnen, R. (April 2002). Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes, 51 (4), 1093-1101. doi:10.2337/diabetes.51.4.1093

Lijnen, R., Maquoi, E., Hansen, L. B., Van Hoef, B., Frederix, L., & Collen, D. (01 March 2002). Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arteriosclerosis, Thrombosis and Vascular Biology, 22 (3), 374-379. doi:10.1161/hq0302.104522

Maquoi, E., Munaut, C., Colige, A., Lambert, C., Frankenne, F., Noël, A., Grams, F., Krell, H.-W., & Foidart, J.-M. (2002). Stimulation of matrix metalloproteinase-9 expression in human fibrosarcoma cells by synthetic matrix metalloproteinase inhibitors. Experimental Cell Research, 275 (1), 110-21. doi:10.1006/excr.2002.5489

Lijnen, R., Maquoi, E., Holvoet, P., Mertens, A., Lupu, F., Morange, P., Alessi, M. C., & Juhan-Vague, I. (June 2001). Adipose tissue expression of gelatinases in mouse models of obesity. Thrombosis and Haemostasis, 85 (6), 1111-1116. doi:10.1055/s-0037-1615971

Maquoi, E., Frankenne, F., Noël, A., Krell, H. W., Grams, F., & Foidart, J.-M. (15 December 2000). Type Iv Collagen Induces Matrix Metalloproteinase 2 Activation in Ht1080 Fibrosarcoma Cells. Experimental Cell Research, 261 (2), 348-59. doi:10.1006/excr.2000.5063

Maquoi, E., Frankenne, F., Baramova, E., Munaut, C., Sounni, N. E., Remacle, A., Noël, A., Murphy, G., & Foidart, J.-M. (14 April 2000). Membrane Type 1 Matrix Metalloproteinase-Associated Degradation of Tissue Inhibitor of Metalloproteinase 2 in Human Tumor Cell Lines. Journal of Biological Chemistry, 275 (15), 11368-78. doi:10.1074/jbc.275.15.11368

Maquoi, E., Munaut, C., Colige, A., Lambert, C., Frankenne, F., Noël, A., Grams, F., Krell, H. W., & Foidart, J.-M. (30 June 1999). Paradoxical Stimulation of Matrix Metalloproteinase-9 Expression in Ht1080 Cells by a Broad-Spectrum Hydroxamate-Based Matrix Metalloproteinase Inhibitor. Annals of the New York Academy of Sciences, 878, 744-6. doi:10.1111/j.1749-6632.1999.tb07779.x

Maquoi, E., Noël, A., Frankenne, F., Angliker, H., Murphy, G., & Foidart, J.-M. (13 March 1998). Inhibition of Matrix Metalloproteinase 2 Maturation and Ht1080 Invasiveness by a Synthetic Furin Inhibitor. FEBS Letters, 424 (3), 262-6. doi:10.1016/S0014-5793(98)00187-2

Maquoi, E., Polette, M., Nawrocki, B., Bischof, P., Noël, A., Pintiaux, A., Santavicca, M., Schaaps, J.-P., Pijnenborg, R., Birembaut, P., & Foidart, J.-M. (May 1997). Expression of Stromelysin-3 in the Human Placenta and Placental Bed. Placenta, 18 (4), 277-85. doi:10.1016/S0143-4004(97)80062-8

Maquoi, E., Noël, A., & Foidart, J.-M. (1997). Matrix metalloproteinases in choriocarcinoma cell lines: a potential regulatory role of extracellular matrix components. In J.-M. Foidart, J. Aplin, P. Kaufmann, ... J.-P. Schaaps, Placenta. Trophoblast Research. Early Pregnancy (pp. 18, Supplement 2, Pages 123-142). Elsevier.

Noël, A., Gilles, C., Bajou, K., Devy, L., Kebers, F., Lewalle, J. M., Maquoi, E., Munaut, C., Remacle, A., & Foidart, J.-M. (1997). Emerging Roles for Proteinases in Cancer. Invasion and Metastasis, 17 (5), 221-39.

Noël, A., Lefebvre, O., Maquoi, E., Vanhoorde, L., Chenard, M. P., Mareel, M., Foidart, J.-M., Basset, P., & Rio, M. C. (1996). Stromelysin-3 expression promotes tumor take in nude mice. Journal of Clinical Investigation, 97, 1924-1930. doi:10.1172/JCI118624